Ahead medical trip to US, Namibian President informs citizens
Namibian President, Hage G. Geingob has informed his citizens of his intention to undergo a seven-day ‘specialised’ medical treatment in the United States after detecting cancerous cells in his body by his medical team on January 19. The President would commence immediate medical treatment following advice from the medical team. In a post on his […]
namibian president, hage g. geingob
Namibian President, Hage G. Geingob has informed his citizens of his intention to undergo a seven-day ‘specialised’ medical treatment in the United States after detecting cancerous cells in his body by his medical team on January 19.
The President would commence immediate medical treatment following advice from the medical team.
In a post on his X handle said Mr. Geingob accepted the medical offer by leading scientists and medical professionals in Los Angeles, California to undergo novel therapy for cancerous cells in the United States of America.
According to the statement the travel, medical, and accommodation expenses of the President will not be incurred by the government.
Insecurity: Nigerian US-based medical practitioner to assist troops in treatment of wounds
1,500 redeployed CBN staff to resume Lagos office Friday
“It reads in parts: “An unintended, but welcome consequence of the transparency with which the President communicated about the cancerous cells has been the outpouring of prayers, and well-wishes, including offers of medical support from Namibians, friends, leading specialist physicians, and scientists from across the globe.
“Whilst 95% of the treatment for the cancerous cells will be carried out in Namibia, the Presidency wishes to confirm that the treatment the President will undergo in the United States of America is limited to seven days. Crucially, the medical technology will be transferred to Namibia and President Geingob will travel with his medical team this will also result in the necessary transfer of advanced medical skills, which will be used for the treatment of other patients in Namibia.”